Literature DB >> 11192871

Understanding delay to medical care for HIV infection: the long-term non-presenter.

J H Samet1, K A Freedberg, J B Savetsky, L M Sullivan, M D Stein.   

Abstract

OBJECTIVE: To examine delayed presentation for HIV testing and primary care in the second decade of the AIDS epidemic.
DESIGN: Cohort study in two urban hospitals in the USA between February 1994 and April 1996.
METHODS: A total of 203 consecutive outpatients on initial HIV primary care presentation were interviewed about sociodemographic characteristics, alcohol and drug use, social support, sexual practices, HIV testing, awareness of possible HIV infection, and CD4 cell count. MAIN OUTCOME MEASURE: Duration of delay to medical presentation in years based on CD4 cell count, factors independently associated with low CD4 cell counts, frequency of awareness of HIV risk before testing.
RESULTS: The estimated mean duration between acquiring HIV infection and initial presentation to primary care was 8.1 years (95% CI 7.5, 8.6) based on our cohort's median initial CD4 cell count of 280/microl. Male sex, older age, and no jail time were associated with lower CD4 cell counts; 34% reported not being aware that they were at risk of HIV before testing. Heterosexual intercourse as a risk behavior for HIV was the most statistically significant factor for personal unawareness of HIV risk. Of those who acknowledged awareness, the mean time between awareness of HIV risk and testing was 2.5 years (median 1.0 year).
CONCLUSION: In the pre-highly active antiretroviral therapy era, HIV-infected patients frequently initiated primary medical care years after initial infection, at a time of advanced immunosuppression. Over one-third of HIV-infected patients were not cognisant of their HIV risk before testing, a condition significantly associated with heterosexual intercourse as the only HIV risk behavior.

Entities:  

Mesh:

Year:  2001        PMID: 11192871     DOI: 10.1097/00002030-200101050-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  65 in total

1.  Causes of hospitalization and perceived access to care among persons newly diagnosed with HIV infection: implications for HIV testing programs.

Authors:  Lokesh Shahani; Christine Hartman; Cathy Troisi; Asha Kapadia; Thomas P Giordano
Journal:  AIDS Patient Care STDS       Date:  2011-12-07       Impact factor: 5.078

2.  A budget impact analysis of rapid human immunodeficiency virus screening in Veterans Administration emergency departments.

Authors:  Risha Gidwani; Matthew Bidwell Goetz; Gerald Kominski; Steven Asch; Kristin Mattocks; Jeffrey H Samet; Amy Justice; Neel Gandhi; Jack Needleman
Journal:  J Emerg Med       Date:  2011-01-28       Impact factor: 1.484

3.  Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.

Authors:  B Castelnuovo; E Chiesa; S Rusconi; F Adorni; M Bongiovanni; S Melzi; P Cicconi; F Tordato; L Meroni; T Bini; A d'Arminio Monforte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-21       Impact factor: 3.267

4.  Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.

Authors:  Bethany L Morris; Callie A Scott; Timothy J Wilkin; Paul E Sax; Roy M Gulick; Kenneth A Freedberg; Bruce R Schackman
Journal:  HIV Clin Trials       Date:  2012 Jan-Feb

5.  Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.

Authors:  Denis Nash; Yingfeng Wu; Batya Elul; David Hoos; Wafaa El Sadr
Journal:  AIDS       Date:  2011-07-31       Impact factor: 4.177

6.  Testing for HIV infection in the United States.

Authors:  Lindsey L Wolf; Rochelle P Walensky
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

7.  Improving outcomes in state AIDS drug assistance programs.

Authors:  Benjamin P Linas; Elena Losina; Annette Rockwell; Rochelle P Walensky; Kevin Cranston; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

8.  Implications and impact of the new US Centers for Disease Control and prevention HIV testing guidelines.

Authors:  Jennifer C Millen; Christian Arbelaez; Rochelle P Walensky
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

9.  Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.

Authors:  Bruce R Schackman; Callie A Scott; Paul E Sax; Elena Losina; Timothy J Wilkin; John E McKinnon; Susan Swindells; Milton C Weinstein; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2007-09-04       Impact factor: 9.079

Review 10.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.